Systemic Mastocytosis with an Associated Myeloid NeoplasmNCIt concept
Preferred Label : Systemic Mastocytosis with an Associated Myeloid Neoplasm;
NCIt synonyms : SM-AHNMD; Systemic Mastocytosis with an Associated Hematological Neoplasm (SM-AHN); SM-AHN; SM-AMN; Systemic Mastocytosis with an Associated Hematologic Neoplasm;
NCIt related terms : Systemic mastocytosis with AHNMD; Systemic Mastocytosis with Associated Clonal Hematological non-Mast-Cell Lineage Disease; Systemic mastocytosis with associated hematological clonal non-mast cell disorder;
NCIt definition : A disorder characterized by systemic infiltration of internal organs by aggregates
of clonal mast cells and the presence of a clonal non-mast cell myeloid neoplasm (e.g.,
myelodysplastic syndrome, myeloproliferative neoplasm, and acute myeloid leukemia).;
https://www.has-sante.fr/jcms/p_3359432/fr/ayvakyt-avapritinib-mastocytose-systemique-agressive-asm https://www.has-sante.fr/jcms/p_3359458/fr/decision-n2022-0278/dc/sem-du-21-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ayvakyt 2022 false false false France adult Systemic Mastocytosis with an Associated Myeloid Neoplasm protein kinase inhibitors avapritinib leukemia, mast-cell treatment outcome insurance, health, reimbursement guidelines for drug use continuity of patient care administration, oral evaluation of the transparency committee avapritinib aggressive systemic mastocytosis mastocytosis, systemic